Научная электронная библиотека
Монографии, изданные в издательстве Российской Академии Естествознания


Курзанов А. Н., Ледванов М. Ю., Быков И. М., Медведев В. Л., Стрыгина Е. А., Бизенкова М. Н., Заболотских Н. В., Ковалев Д. В., Стукова Н. Ю.,

Литература к главе 10

1. Бизенкова М.Н., Курзанов А.Н. Остеотропные эффекты паратгормон-родственного белка // Современные проблемы науки и образования. – 2017. – № 2; URL: http://science-education.ru/ru/article/view?id=26328.

2. Курзанов А.Н., Быков И.М., Ледванов М.Ю. Паратиреоидный гормон-родственный белок – современные представления о структуре, биохимических характеристиках и физиологической роли в организме // Современные проблемы науки и образования. – 2016. – № 6; URL: http://science-education.ru/ru/article/view?id=25543.

3. Медведев В.Л., Стрыгина Е.А., Курзанов А.Н. Паратиреоидный гормон-родственный белок и рак предстательной железы. Кубанский научный медицинский вестник. 2017; 1(1): 145-154. https://doi.org/10.25207/1608-6228-2017-1-145-154.

4. Adamson I.Y., Young L., King G.M. Reciprocal epithelial: fibroblast interactions in the control of fetal and adult rat lung cells in culture. Exp Lung Res. 1991; 17: 821–835.

5. Adamson I.Y. Relationship of mesenchymal changes to alveolar epithelial cell differentiation in fetal rat lung. Anat Embryol (Berl). 1992; 185: 275–280.

6. Alcorn D., Adamson T.M., Lambert T.F. et al. Morphological effects of chronic tracheal ligation and drainage in the fetal lamb lung. J Anat. 1997; 123: 649–660.

7. Amabile N., Heiss C., Real W.M., et al. Circulating endothelial microparticles levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med. 1994; 149: 423–9.

8. Barbera L.A., Steinhorn R.H., Roca J., et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994; 149: 422–9.

9. Barnes P.J. Nitric oxide and airway disease. Ann Med. 1995; 27: 389–93.

10. Bellusci S., Furuta Y., Rush M.G. et al. Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development. 1997; 124: 53–63.

11. Bergwitz C., Klein P., Kohno H. et al. Identification, functional characterization, and developmental expression of two nonallelic parathyroid hormone (PTH)/PTH-related peptide receptor isoforms in Xenopus laevis (Daudin). Endocrinology. 1998; 139: 723–732.

12. Brandt D.W., Burton D.W., Gazdar A.F et al. All major lung cancer cell types produce parathyroid hormone-like protein: heterogeneity assessed by high performance liquid chromatography. Endocrinology. 1991; 129: 2466–2470.

13. Brockhoff B., Schreckenberg R., Forst S. et al. Effect of nitric oxide deficiency on the pulmonary PTHrP system. J Cell Mol Med. 2017; 21 (1): 96-106. doi: 10.1111 / jcmm.12942.

14. Buch S., Han R.N.N., Liu J. et al. Basic fibroblast growth factor and growth factor receptor gene expression in 85 % O2-exposed rat lung. Am J Physiol Lung Cell Mol Physiol. 1995; 268: L455-L464.

15. Buckley S., Bui K.C., Hussain M. Warburton D. Dynamics of TGF-β3 peptide activity during rat alveolar epithelial cell proliferative recovery from acute hyperoxia. Am J Physiol Lung Cell Mol Physiol. 1996; 271: L54-L60.

16. Burtis W.J., Brady T.G., Orloff J.J. et al. Immunochemical characterization ofcirculating parathyroid hormone-related protein in patients with humoralhypercalcemia of cancer. N Engl J Med 1990; 322: 1106–1112.

17. Cai Z., Chen Q., Chen J. et al. Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia. 2009; 11:228–236. doi: 10.1593/neo.81282.

18. Campos R.V., Asa S.L., Drucker D.J. Immunocytochemical localization of parathyroid hormone-like peptide in the rat fetus. Cancer Res. 1991; 51(23 Pt 1): 6351-7.

19. Cardoso, W.V. Molecular regulation of lung development. Annu. Rev. Physiol. 2001; 63: 471–494.

20. Clements, J.A., J. Nellenbogen, H.J. Trahan. Pulmonary surfactant and evolution of the lungs. Science. 1970; 169: 603–604.

21. Coggins M.P., Bloch K.D. Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol. 2007; 27: 1877–985.

22. Coleman R.E. Skeletal complications of malignancy. Cancer 1997; 80: 1588–1594.

23. Daniels C.B., Orgeig S. Pulmonary surfactant: the key to the evolution of air breathing. News Physiol. Sci. 2003; 18: 151–157.

24. DeMarco V.G., Habibi J., Whaley-Connell A.T. et al. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rats. Am J Physiol Heart Circ Physiol. 2009; 297: H1128–39.

25. Demayo F., Minoo P., Plopper C.G. et al. Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process? Am. J. Physiol. (Lung Cell Mol. Physiol.) 2002; 283: L510–L517.

26. Deng X., Tannehill-Gregg S.H., Nadella M.V. et al. Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases. Clin Exp Metastasis. 2007; 24:107–119. doi: 10.1007/s10585-007-9059-9.

27. Doi T., Sugimoto K., Ruttenstock E. et al Prenatal treatment with retinoic acid activates parathyroid hormone-related protein signaling in the nitrofen-induced hypoplastic lung. Pediatr Surg Int. 2011; 27(1): 47–52. https://doi.org/10.1007/s00383-010-2726-y.

28. Edwards Y.S. Stretch stimulation: its effects on alveolar type II cell function in the lung. Comp Biochem Physiol A Physiol. 2001; 129: 245–260.

29. Farach-Carson M.C., Lin S-H., Nalty T., Satcher R.L. Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow? Front Oncol. 2017; 7: 163. doi: 10.3389/fonc.2017.00163.

30. Faridy E.E., Permutt S., Riley R.L. Effect of ventilation on surface forces in excised dogs′lungs. J Appl Physiol. 1966; 21: 1453–1462.

31. Floegel J., Uhlig S. Kidney calling lung and call back: how organs talk to each other. Nephrol Dial Transplant. 2010; 25: 32–4.

32. Foley J., P. Dann J. Hong J. et al. Parathyroid hormone–related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development. 2001; 128:513–525.

33. Fraser W.D., Robinson J., Lawton R. et al. Clinical and laboratory studies of anew immunoradiometric assay of parathyroid hormone-related protein. Clin Chem. 1993; 39: 414–419.

34. Furugaki K., Moriya Y., Iwai T. et al. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292. Clin. Exp. Metastasis. 2011; 28(7): 649–659.

35. Gao Y., Raj U.J. Parathyroid Hormone-Related Protein (PTHrP): A New Role as a Pulmonary Vasodilator at Birth. Pediatric Research. 1999; 45: 302A. https://doi.org/10.1203/00006450-199904020-01799.

36. Gaston B., Drazen J.M., Loscalzo J. et al. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994; 149: 538–51.

37. Grindley J.C., Bellusci S., Perkins D., Hogan B.L.M. Evidence for the involvement of the Gli gene family in embryonic mouse lung development. Dev Biol. 1997;188:337–348. doi: 10.1006/dbio.1997.8644.

38. Hacker A.D. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension. Biochem Pharmcol. 1993; 45: 2475–81.

39. Han R.N.N, Han V.K.M., Buch S. et al. Insulin-like growth factor-I and type I insulin-like growth factor receptor in 85 % O2-exposed rat lung. Am J Physiol Lung Cell Mol Physiol. 1996; 271: L139-L149.

40. Hastings R.H., Asirvatham A., Quintana R. et al. Parathyroid hormone-related protein-(38–64) regulates lung cell proliferation after silica injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2002; 283(1): L12-L21. 01 https://doi.org/10.1152/ajplung.00308.2001.

41. Hastings R.H., Berg J.T., Summers-Torres D. et al. Parathyroid hormone-related protein reduces alveolar epithelial cell proliferation during lung injury in rats. Am J Physiol Lung Cell Mol Physiol, 2000; 279: L194-L200.

42. Hastings R.H., Summers-Torres D., Cheung T.C. et al. Parathyroid hormone-related protein, an autocrine regulatory factor for alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 1996; 270(3 Pt 1): L353-L361.

43. Hastings R.H., Araiza F., Burton D.W., Deftos L.J. Role of parathyroid hormone-related protein in lung cancer cell survival. Chest. 2004; 125(5 Suppl): 150S.10.1378/chest.125.5_suppl.150S.

44. Hastings R.H., Burton D.W., Quintana R.A. et al. Parathyroid hormone-related protein regulates the growth of orthotopic human lung tumors in athymic mice. Cancer. 2001; 92: 1402–1410.

45. Hastings R.H., Laux A.M., Casillas A. et al. Sex-specific survival advantage with PTHrP in non-small cell lung carcinoma patients. Clin Cancer Res. 2006; 12: 499–506.

46. Hastings R.H., Summers-Torres D., Yaszay B. et al. Parathyroid hormone-related protein, an autocrine growth inhibitor of alveolar type II cells. Am J Physiol Lung Cell Mol Physiol. 1997; 272(3 Pt 1): L394 – L399.

47. Hastings R.H. Parathyroid hormone-related protein and lung biology. Respir Physiol Neurobiol. 2004; 142(2-3):95-113.

48. Hastings R.H., Burton D.W., Nefzi A. et al. Combinatorial library discovery of small molecule inhibitors of lung cancer proliferation and parathyroid hormone-related protein expression. Cancer Biol Ther. 2010; 10(10):1067-75. doi: 10.4161/cbt.10.10.13374.

49. Hastings R.H., Duong H., Burton D.W., Deftos LJ. Alveolar epithelial cells express and secrete parathyroid hormone-related protein. Am J Respir Cell Mol Biol. 1994; 11(6): 701-6.

50. Hastings R.H., Montgrain P.R., Quintana R. et al. Cell cycle actions of parathyroid hormone-related protein in non-small cell lung carcinoma. Am J Physiol Lung Cell Mol Physiol. 2009; 297(4): L578-85. doi: 10.1152/ajplung.90560.2008.

51. Hastings R.H., Montgrain P.R., Quintana R.A. et al. Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression. J Cancer Res Clin Oncol. 2017 Aug; 143(8): 1395-1407. doi: 10.1007/s00432-017-2396-4.

52. Hu E., Tontonoz P., Spiegelman B.M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARgamma and C/EBP alpha. Proc. Natl. Acad. Sci. USA. 1995; 92: 9856–9860.

53. Hume R., Kelly R., Cossar D. et al. Self-differentiation of human fetal lung organ culture: the role of prostaglandins PGE2 and PGF2 alpha. Exp Cell Res. 1991; 194: 111–117.

54. Iguchi H., Tanaka S., Ozawa Y. et al. An experimental model of bone metastasis by human lung cancer cells: The role of parathyroid hormone-related protein in bone metastasis. Cancer Res. 1996; 56: 4040–4043.

55. Jiang B., Morimoto S., Yang J. et al. Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J. Cardiovasc. Pharmacol. 1998; 31: S142–S144.

56. Kaesler S., Luscher B., Ruther U. Transcriptional activity of GLI1 is negatively regulated by protein kinase A. Biol. Chem. 2000; 381: 545–551.

57. Kalk P., Mach A., Thone-Reineke C., et al. Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system. Can J Physiol Pharmacol. 2008; 86: 541–5.

58. Karaplis A.C. PTHrP: novel roles in skeletal biology. Curr Pharm Des. 2001; 7: 655–670.

59. Karperien M., van Dijk T.B., Hoeijmakers T., et al. Expression pattern of parathyroid hormone/parathyroid hormone-related peptide receptor mRNA in mouse postimplantation embryos indicates involvement in multiple developmental processes. Mech Dev.1994; 47: 29–42

60. Kerem A., Yin J., Kaestle S.M., et al. Lung endothelial dysfunction in congestive heart failure: role of impaired Ca 2+signaling and cytoskeletal reorganization. Circ Res. 2010; 106: 1103–16.

61. Kobs R.W., Chesler N.C. The mechanobiology of pulmonary vascular remodelling in the congential absence of eNOS. Biomechn Model Mechanobiol. 2006; 5: 217–25.

62. Krebs M., Sakurai R., Torday J.S., Rehan V.K. Evidence for in Vivo Nicotine-Induced Alveolar Interstitial Fibroblast-to-Myofibroblast Transdifferentiation. Exp Lung Res. 2010; 36(7): 390–398. doi: 10.3109 / 01902141003714023

63. Lebeche D., Malpel S., Cardoso W.V. Fibroblast growth factor interactions in the developing lung. Mech Dev. 1999; 86: 125–136.

64. Lechner A.J., Winston D.C., Bauman J.E. Lung mechanics, cellularity, and surfactant after prenatal starvation in guinea pigs. J Appl Physiol. 1986; 60: 1610–1614.

65. Lee J.W., Gonzalez R.F., Chapin C.J., et al. Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes. Am J Physiol Lung Cell Mol Physiol. 2005; 288: L950–7.

66. Lee K., Deeds J.D., Segre G.V. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology. 1995; 136(2): 453-63.

67. Li X., Drucker D.J. Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell line. Cancer Res. 1993; 53: 2980–2986.

68. Litingtung Y., Lei L., Westphal H., Chiang C. Sonic hedgehog is essential to foregut development. Nat Genet. 1998; 20: 58–61. doi: 10.1038/1717.

69. Liu M., Tanswell A.K., Post M. Mechanical force-inducedsignal transduction in lung cells. Am J Physiol Lung Cell Mol Physiol. 1999; 277: L667–683.

70. Lopez-Lopez J.G., Moral-Sanz J., Frazziano G., et al. Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. Am J Physiol Lung Cell Mol Physiol. 2008; 295: L727–32.

71. Lorch G., Gilmore J.L., Koltz P.F., et al. Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. Br. J. Cancer. 2007; 97(2): 183–193.

72. Maina J.N. Structure, function and evolution of the gas exchangers: comparative perspectives. J. Anat. 2002; 201: 281–304.

73. Maina J.N. Fundamental structural aspects and features in the bioengineering of the gas exchangers: comparative perspectives. Adv. Anat. Embryol. Cell Biol. 2002; 163: 1–112.

74. Maina J.N. Some recent advances on the study and understanding of the functional design of the avian lung: morphological and morphometric perspectives. Biol. Rev. Camb. Philos. Soc. 2002; 77: 97–152.

75. Maksvytis H.J., Vaccaro C., Brody J.S. Isolation and characterization of the lipid-containing interstitial cell from the developing rat lung. Lab Invest. 1981; 45: 248–259.

76. Mariani T.J., Roby J.D., Mecham R.P. et al., Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor-beta as a mediator of fibrosis. Am J Pathol. 1996; 148: 151-164.

77. McCray P.B. Jr, Bettencourt J.D., Bastacky J. Secretion of lung fluid by the developing fetal rat alveolar epithelium in organ culture. Am J Respir Cell Mol Biol. 1992; 6: 609–616.

78. McDowell S.A., Gammon K., Zingarelli B., et al. Inhibition of nitric oxide restores surfactant gene expression following nickel-induced acute lung injury. Am J Respir Cell Mol Biol. 2003; 28: 188–98.

79. McGowan S., Torday J.S. Pulmonary Lipid Laden Fibroblasts. Annu Rev Physiol. 1999; 59: 45–64.

80. McGowan S.E., Torday J.S. The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development. Annu Rev Physiol. 1997; 59: 43–62.

81. Meban C. Thickness of the air-blood barriers in vertebrate lungs. J. Anat. 1980; 131: 299–307.

82. Michaeloudes C., Sukkar M.B., Khorasani N.M., et al. TGF-bregulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells. Am J Physiol Cell Mol Physiol. 2011; 300: L295–304.

83. Miki T., Yano S., Hanibuchi M., et al. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice. Int J Cancer. 2004; 108(4): 511–5.10.1002/ijc.11586.

84. Miller B.E., Dethloff L.A., Gladen B.C., Hook G.E. Progression of type II cell hypertrophy and hyperplasia during silica-induced pulmonary inflammation. Lab Invest. 1987; 57: 546-54.

85. Minke van Tuyl, Martin Post. From fruitflies to mammals: mechanisms of signalling via the Sonic hedgehog pathway in lung development. Respir Res. 2000; 1(1): 30–35.

86. Moessinger A.C., Harding R., Adamson T.M., et al. Role of lung fluid volume in growth and maturation of the fetal sheep lung. J Clin Invest. 1990; 86: 1270–1277.

87. Montgrain P.R., Deftos L.J., Arenberg D., et al. Prognostic implications of parathyroid hormone-related protein in males and females with non-small-cell lung cancer. Clin Lung Cancer. 2011; 12(3):197-205. doi: 10.1016/j.cllc.2011.03.018.

88. Montgrain P.R., Phun J., Werff R.V., et al. Parathyroid-hormone-related protein signaling mechanisms in lung carcinoma growth inhibition. Springerplus. 2015; 4: 268. doi: 10.1186/s40064-015-1017-4.

89. Montgrain P.R., Quintana R., Rascon Y., et al. Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer. Cancer. 2007; 110(6): 1313-20.

90. Morales E., Sakurai R., Husain S., et. al. Nebulized PPARγ agonists: a novel approach to augment neonatal lung maturation and injury repair in rats. Pediatr Res. 2014; 75(5): 631-40. doi: 10.1038/pr.2014.8.

91. Moseley J.M., Kubota M., Diefenbach-Jagger H., et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A. 1987; 84(14):5048-52.

92. Muguruma H., Yano S., Kakiuchi S., et al. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Clin Cancer Res. 2005; 11:8822–8828. doi: 10.1158/1078-0432.CCR-05-1335.

93. Nelson G.H. McPherson J.C.Jr. Respiratory distress syndrome in various cultures and a possible role of diet. In: Lung Biology in Health and Disease: Pulmonary Development, edited by Nelson G.H. New York: Dekker, 1985; 27: 159–178.

94. Nicholas T.E., Barr H.A. Control of release of surfactant phospholipids in the isolated perfused rat lung. J Appl Physiol. 1981; 51: 90–98.

95. Nicholas T.E., Bar H.A. The release of surfactant in rat lung by brief periods of hyperventilation. Respir Physiol. 1983; 52:69–83.

96. Nici L., Medina M., Frackelton A.R. The epidermal growth factor receptor network in type 2 pneumocytes exposed to hyperoxia in vitro. Am J Physiol Lung Cell Mol Physiol. 1996; 270: L242-L250.

97. Nielsen H.C., Torday J.S. Sex differences in avian embryo pulmonary surfactant production: evidence for sex chromosome involvement. Endocrinology. 1985; 117:31–37.

98. Nishigaki Y., Ohsaki Y., Toyoshima E., Kikuchi K. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients. Clin Cancer Res. 1999; 5(6): 1473-81.

99. Nunez J.S., Torday J.S. Fetal rat lung type II cells and fibroblasts actively recruit surfactant substrate. J Nutr. 1995; 125: 1639S–1644S.

100. Oyarzun M.J., Clements J.A., Baritussio A. Ventilation enhances pulmonary alveolar clearance of radioactive dipalmi-toyl phosphatidylcholine in liposomes. Am Rev Respir Dis. 1980; 121: 709–721.

101. Pecherstorfer M., Schilling T., Blind E., et al. Parathyroid hormone-relatedprotein and life expectancy in hypercalcemic cancer patients. J Clin Endo-crinol Metab. 1994; 78: 1268–1270.

102. Pepicelli C.V., Lewis P.M., McMahon A.P. Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol. 1998; 8: 1083–1086.

103. Piiper J. Alveolar-capillary gas transfer in lungs: development of concepts and current state. Adv. Exp. Med. Biol. 1994; 345: 7–14.

104. Prisk G.K. Microgravity and the lung. J Appl Physiol. 2000; 89(1): 385-96.

105. Prisk G.K. Microgravity and the respiratory system Eur Respir J. 2014; 43(5): 1459-71. doi: 10.1183/09031936.00001414.

106. Rehan V., Torday J. Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochem Biophys. 2003; 38: 239–250.

107. Rehan V.K., John S. Torday J.S. PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung. PPAR Res. 2012; 289867. doi: 10.1155/2012/289867.

108. Rehan V.K., Torday J.S. Exploiting the PTHrP signaling pathway to treat chronic lung disease. Drugs of today 2007; 43(5): 317-31. DOI: 10.1358/dot.2007.43.5.1062665.

109. Rehan V.K., Asotra K., Torday J.S. The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung. 2009; 187: 281–9.

110. Rehan V.K., Sakurai R., Wang Y., et al. Reversal of nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of parathyroid hormone-related protein signalling. Lung. 2007; 185: 151–9.

111. Rehan V.K., Torday J.S. The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury. Antioxid Redox Signal. 2014; 21(13): 1893-1904. doi: 10.1089/ars.2013.5793.

112. Rehan V.K., Wang Y., Sugano S., et al. Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation. Am J Physiol Lung Cell Mol Physiol. 2005; 289: L667–L676.

113. Rizzoli R., Thiebaud D., Bundred N., et al. Serum parathyroid hormone-related protein Levels An Dresponse to bisphosphonate Treatment in hypercalcemia of malignancy. J Clin Endocrinol Metab. 1999; 84:3545–3550.

114. Rodriguez A., Viscardi R.M., Torday J.S. Fetal androgen exposure inhibits fetal rat lung fibroblast lipid uptake and release. Exp Lung Res. 2001; 27: 13–24.

115. Romer A.S. Man and the Vertebrates, Vol. 1. Harmonds-worth, GB: Penguin, 1954.

116. Rubin L.P., Torday J.S. Parathyroid hormone-related protein (PTHrP) biology in fetal lung development. In: Endocrinology of the Lung, edited by Mendelson CR. Totowa, NJ: Humana, 2000, p. 269–297.

117. Rubin L.P., Kovacs C.S., De Paepe M.E., et al., Arrested Pulmonary Alveolar Cytodifferentiation and Defective Surfactant Synthesis in Mice Missing the Gene for Parathyroid Hormone-Related Protein Dev Dyn. 2004; 230 (2): 278-89.

118. Rubin L.P., Kifor O., Hua J., et al. Parathyroid hormone (PTH) and PTH-related protein stimulate surfactant phospholipid synthesis in rat fetal lung, apparently by a mesenchymal-epithelial mechanism. Biochim. Biophys. Acta. 1994; 1223: 91–100.

119. Sakaguchi S., Goto H., Hanibuchi M., et al. Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice. Clin Exp Metastasis. 2010; 27(5):351–359. 10.1007/s10585-010-9333-0.

120. Sakai T., Satoh K., Matsushima K., et al. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am J Respir Cell Mol Biol. 1997; 16: 388-397.

121. Sakurai R., Lee C., Shen H., et al. A Combination of the Aerosolized PPAR-γ Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats. Neonatology. 2018; 113(4): 296-304. doi: 10.1159/000486188.

122. Sanchez-Esteban J., Cicchiello L.A., Wang Y., et al. Mechanical stretch promotes alveolar epithelial type II cell differentiation. J Appl Physiol. 2001; 91: 589–595.

123. Sasaki Y., Morimoto T., Saito H., et al. The role of parathyroid hormone-related protein in intra-tracheal fluid. Endocr J 2000; 47: 169–175.

124. Schermer D.T., Chan S.D., Bruce R., et al. Chicken parathyroid hormone-related protein and its expression during embryologic development. J. Bone Miner. Res. 1991; 6:149–155.

125. Schultz C.J., Torres E., Londos C., Torday J.S. Role of adipocyte differentiation-related protein in surfactant phospholipids synthesis by type II cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2002; 283: L288–L296.

126. Shannon J.M. Induction of alveolar type II cell differentiation in fetal tracheal epithelium by grafted distal lung mesenchyme. Dev Biol. 1994; 166: 600–614.

127. Sharifi A.M, Akbarloo N., Darabi R. Investigation of local ACE activity and structural alterations during development of L-NAME-induced hypertension. Pharmacol Res. 2005; 52: 438–44.

128. Simon R.H., Paine R. Participation of pulmonary alveolar epithelial cells in lung inflammation. J Lab Clin Med. 1995; 126: 108-118.

129. Smith B., Post M. Fibroblast-pneumonocyte factor. Am J Physiol. 1989;
257: 1, 174–178.

130. Sorokin S. Recent work on the developing lungs. In: deHaan R.L., Ursprung H., editors. Organogenesis. New York: Holt; 1965. pp. 467–491.

131. Speziale M.V., Mannino F.L., Hastings R.H., Deftos L.J. Parathyroid hormone-related protein in tracheal aspirates of newborn infants. Pediatr Res. 1998; 43: 660–665.

132. Stern J-B., Bernard O., Paugam C., et al. Prenatal treatment with retinoic acid activates parathyroid hormone-related protein signaling in the nitrofen-induced hypoplastic lung. Pediatr Surg Int. 2011; 27(1): 47–52. https://doi.org/10.1007/s00383-010-2726-y.

133. Stern J-B., Bernard O., Paugam C., et al. Parathyroid hormone-related protein in epithelial lining fluid in humans negatively correlates with the severity of lung injury. Chest. 2002; 121: 852–7.

134. Stewart A.F. Hypercalcemia associated with cancer. N Engl J Med. 2005; 352:373–379.

135. Sun P., Wang J. Effect of nitric oxide lung surfactant secretion. Exptl Lung Res. 2003; 29: 303–14.

136. Taderera J.V. Control of lung differentiation in vitro. Dev Biol. 1967; 16: 489–512.

137. Te K.G., Reggiani C. Skeletal muscle fibre type specification during embryonic development. J. Muscle Res. Cell Motil. 2002; 23:65–69.

138. Torday J.S., Rehan V.K. Deconvoluting Lung Evolution Using Functional/Comparative Genomics. American Journal of Respiratory Cell and Molecular Biology. 2004; 31(1): 8-12.

139. Torday J.S., Rehan V.K. Lung evolution as a cipher for physiology. Physiol Genomics. 2009; 38(1): 1–6.

140. Torday J.S., Rehan V.K. On the evolution of the pulmonary alveolar lipofibroblast. Exp Cell Res. 2016; 340(2): 215-9. doi: 10.1016/j.yexcr.2015.12.004.

141. Torday J.S., Rehan V.K. The evolutionary continuum from lung development to homeostasis and repair Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 292: L608-L611.

142. Torday J.S., Hua J., Slavin R. Metabolism and fate of fetal rat lung fibroblast neutral lipids. Biochim Biophys Acta. 1995; 1254: 198–206.

143. Torday J.S., Rehan V.K. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res., 2007; 62 (1): 2–7.

144. Torday J.S., Rehan V.K. Evolutionary Biology, Cell-Cell Signaling and Complex Disease. Hoboken, NJ: Wiley, 2012.

145. Torday J.S., Rehan V.K. Mechanotransduction determines the structure and function of lung and bone: a theoretical model for the pathophysiology of chronic disease. Cell Biochem Biophys. 2003; 37: 235–246.

146. Torday J.S., Sanchez-Esteban J., Rubin L.P. Paracrine mediators of mechanotransduction in lung development. Am J Med Sci. 1998; 316: 205–208.

147. Torday J.S., Sun H., Qin J. Prostaglandin E2 integrates the effects of fluid distension and glucocorticoid on lung maturation. Am J Physiol Lung Cell Mol Physiol. 1998; 274: L106–L111.

148. Torday J.S., Sun H., Wang L., et al. Leptin mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation. Am J Physiol Lung Cell Mol Physiol. 2002; 282: L405–L410.

149. Torday J.S., Torday D.P., Gutnick J., Rehan V. Biologic role of fetal lung fibroblast triglycerides as antioxidants. Pediatr Res 49: 843–849, 2001.

150. Torday J.S., Tsai S.-W., Sun H., Rubin L.P. The physiologic role of fluid deformation in fetal lung development. Cellular deformation: Mechanics and Mechanisms of Physiologic Response. Am J Med Sci. 1998; 316: 208–218.

151. Torday J.S. Parathyroid hormone-related protein is a gravisensor in lung and bone cell biology. Adv Space Res. 2003; 32:1569–76. doi:10.1016/S0273-1177(03)90397-8

152. Torday J.S. Cellular timing of fetal lung development. Semin. Perinatol. 1992; 16:130–139.

153. Torday J.S., Torres E., Rehan V.K. The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr. Pathol. Mol. Med. 2003; 22: 189–207.

154. Torday J.S., Rehan V.K. Stretch-stimulated surfactant synthesis is coordinated by the paracrine actions of PTHrP and leptin. Am J Physiol Lung Cell Mol Physiol. 2002; 283: L130–L135.

155. Uhal B.D. Cell cycle kinetics in the alveolar epithelium. Am J Physiol Lung Cell Mol Physiol. 1997; 272: L1031-L1045.

156. Uy H.L., Mundy G.R., Boyce B.F., et al. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Cancer Res. 1997; 57: 3194–3199.

157. Valino F., Casals C., Guerrero R., et al. Inhaled nitric oxide affects endogenous surfactant in experimental lung transplantation. Transplantation. 2004; 77: 812–8.

158. Vyas-Read S., Shaul P.W., Yuhanna I.S., et al. Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2007; 293: L212–21.

159. Wang Y., Santos J., Sakurai R., et al. Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res. 2009; 65(2):150-5. doi: 10.1203/PDR.0b013e3181938c40.

160. Weibel E.R., Taylor C.R., Bolis L. 1998. Principles of Animal Design. Cambridge University Press. 1998; pp. 178–185.

161. Wirtz H.R., Dobbs LG. Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 1990; 250:1266–1269.

162. Wu C.E., Wang C.W., Huang W.K., et al. Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resection. Jpn J Clin Oncol. 2015; 45(3):267-73. doi: 10.1093/jjco/hyu202.

163. Wyszogrodski I., Kyei-Aboagye K., Taeusch H.W.Jr, Avery E. Surfactant inactivation by hyperventilation: conservation by end-expiratory pressure. J Appl Physiol. 1975; 38: 461–466.

164. Yildrim A.O., Bulau P., Zakrzewicz D., et al. Increased protein argininemethylation in chronic hypoxia. Am J Respir Cell Mol Biol. 2006; 35: 436–43.

165. Zhao J., Chen H., Wang Y.L., Warburton D. Abrogation of tumor necrosis factor-alpha converting enzyme inhibits embryonic lung morphogenesis in culture. Int J Dev Biol. 2001; 45: 623–631.

166. Zhao Y-Y., Zhao Y.D., Mirza M.K., et al. Persistent eNOS activation secondary to caveolin1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest. 2009; 119: 2009–18.

Предлагаем вашему вниманию журналы, издающиеся в издательстве «Академия Естествознания»
(Высокий импакт-фактор РИНЦ, тематика журналов охватывает все научные направления)

«Фундаментальные исследования» список ВАК ИФ РИНЦ = 1.252